Jack Phillips is Chief Executive Officer of Accelerate Diagnostics, Inc. Currently has a direct ownership of 162,919 shares of AXDX, which is worth approximately $281,849. The most recent transaction as insider was on May 15, 2023, when has been sold 7,940 shares (Common Stock) at a price of $0.69 per share, resulting in proceeds of $5,478. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 163K
0% 3M change
193.02% 12M change
Total Value Held $281,849

Jack Phillips Transaction History

Date Transaction Value Shares Traded Shares Held Form
May 15 2023
SELL
Open market or private sale
$5,478 $0.69 p/Share
7,940 Reduced 1.59%
492,638 Common Stock
May 15 2023
BUY
Exercise of conversion of derivative security
-
17,217 Added 3.33%
500,578 Common Stock
Apr 13 2023
SELL
Open market or private sale
$4,838 $0.65 p/Share
7,444 Reduced 1.52%
483,361 Common Stock
Apr 13 2023
BUY
Exercise of conversion of derivative security
-
17,216 Added 3.39%
490,805 Common Stock
Mar 13 2023
SELL
Open market or private sale
$3,650 $0.49 p/Share
7,451 Reduced 1.55%
473,589 Common Stock
Mar 13 2023
BUY
Exercise of conversion of derivative security
-
17,217 Added 3.46%
481,040 Common Stock
Mar 08 2023
SELL
Open market or private sale
$73,148 $0.47 p/Share
155,635 Reduced 25.12%
463,823 Common Stock
Mar 08 2023
BUY
Exercise of conversion of derivative security
-
350,000 Added 36.1%
619,458 Common Stock
Feb 13 2023
SELL
Open market or private sale
$5,160 $0.6 p/Share
8,601 Reduced 3.09%
269,458 Common Stock
Feb 13 2023
BUY
Exercise of conversion of derivative security
-
17,216 Added 5.83%
278,059 Common Stock
Feb 01 2023
BUY
Exercise of conversion of derivative security
-
10,000 Added 3.69%
260,843 Common Stock
Jan 13 2023
SELL
Open market or private sale
$5,801 $0.69 p/Share
8,408 Reduced 3.24%
250,843 Common Stock
Jan 13 2023
BUY
Exercise of conversion of derivative security
-
17,216 Added 6.23%
259,251 Common Stock
Jun 22 2022
SELL
Open market or private sale
$25,660 $0.91 p/Share
28,198 Reduced 10.43%
242,035 Common Stock
Jun 22 2022
BUY
Exercise of conversion of derivative security
-
62,160 Added 18.7%
270,233 Common Stock
Apr 28 2022
SELL
Open market or private sale
$82,034 $0.98 p/Share
83,708 Reduced 28.69%
208,073 Common Stock
Apr 26 2022
BUY
Exercise of conversion of derivative security
-
168,396 Added 36.59%
291,781 Common Stock
Feb 01 2022
SELL
Open market or private sale
$11,909 $3.26 p/Share
3,653 Reduced 2.88%
123,385 Common Stock
Feb 01 2022
BUY
Exercise of conversion of derivative security
-
10,000 Added 7.3%
127,038 Common Stock
Sep 30 2021
BUY
Grant, award, or other acquisition
$33,331 $7.68 p/Share
4,340 Added 3.58%
117,038 Common Stock
Jun 22 2021
SELL
Open market or private sale
$186,423 $7.94 p/Share
23,479 Reduced 17.24%
112,698 Common Stock
Jun 22 2021
BUY
Exercise of conversion of derivative security
-
62,160 Added 31.34%
136,177 Common Stock
May 13 2021
SELL
Open market or private sale
$169,433 $6.76 p/Share
25,064 Reduced 25.3%
74,017 Common Stock
May 12 2021
BUY
Exercise of conversion of derivative security
-
79,893 Added 44.64%
99,081 Common Stock
Apr 09 2021
BUY
Grant, award, or other acquisition
$33,331 $7.68 p/Share
4,340 Added 18.45%
19,188 Common Stock
JP

Jack Phillips

Chief Executive Officer
Tucson, AZ

Track Institutional and Insider Activities on AXDX

Follow Accelerate Diagnostics, Inc and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells AXDX shares.

Notify only if

Insider Trading

Get notified when an Accelerate Diagnostics, Inc insider buys or sells AXDX shares.

Notify only if

News

Receive news related to Accelerate Diagnostics, Inc

Track Activities on AXDX